Acute pulmonary embolism;Die akute Lungenarterienembloie

Anaesthesist

Volumn 51, Issue 5, 2002, Pages 427-445

  Walther, A ^a   Bottiger B W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; CLINICAL FEATURE; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREVALENCE; REPERFUSION; REVIEW; ACUTE DISEASE; EMBOLECTOMY; FIBRINOLYTIC THERAPY; PULMONARY ARTERY;

ACUTE DISEASE; EMBOLECTOMY; HUMANS; PULMONARY ARTERY; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 0036277705     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0315-8     Document Type: Review

References (62)

1. The diagnosis of venous thromboembolism: An overview
2. Die akute thrombembolie der lunge. Klinik - Pathophysiologie - Diagnostik - Therapie
3. Efficacy and safety of thrombolytic therapy after initially unsuccessful resuscitation: A prospective clinical trial
4. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism
5. Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest
6. Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets
7. High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism
8. Acute right heart failure: Pathophysiology, recognition, and pharmacological management
9. Inhaled nitric oxide in patients with pulmonary embolism
10. For the Standards of Care Comittee of the British Thoracic Society. Suspected acute pulmonary embolism: A practical approach
11. A standard heparin nomogram for the management of heparin therapy
12. PALMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator multicenter study 2
13. Pulmonary physiology during pulmonary embolism
14. Thrombolysis using plasminogen activator and heparin reduces cerebral no-refiow after resuscitation from cardiac arrest: An experimental study in the cat
15. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs
16. Pulmonary embolism: Epidemiology
17. Pulmonary embolism
18. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
19. Recombinant tissue-type plasminogen activator versus a novel dosing regime of urokinase in acute pulmonary embolism: A randomized controlled multicenter trial
20. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial
21. Akute lungenembolie. Behandlung nach schweregraden
22. Medical compared with surgical treatment for massive pulmonary embolism
23. Acute pulmonary embolism: Diagnosis with MR angiography
24. Guide to anticoagulant therapy. Part 1: Heparin
25. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals
26. Modified surgical concept for fulminant pulmonary embolism
27. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
28. Natural history of postoperative deep-vein thrombosis
29. Thrombolytic therapy and pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors
30. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry
31. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator
32. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism
33. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry
34. A randomized trial of a single bolus dosage regime of recombinant tissue plasminogen activator in patients with acute pulmonary embolism
35. Diagnosis of pulmonary embolism with magnetic resonance angiography
36. Lungenarterienembolie auf der intensivstation
37. Akute lungenembolie. Klinik, diagnostik und therapie
38. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Immediate clinical and hemodynamic outcome and one-year follow-up
39. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism; A european multicenter double-blind trial
40. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thromolysis
41. Thrombolytic therapy for postoperative pulmonary embolism
42. The spectrum of pulmonary embolism. Clinicopathologic correlations
43. Prevention of venous thromboembolism. European consensus conference
44. Circulatory failure in acute pulmonary embolism
45. The role of suspicion in the diagnosis of pulmonary embolism
46. Value of the Ventilation/Perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)
47. Pulmonary embolism. An appraisal of therapy in 516 cases
48. Diagnostik der lungenarterienembolie
49. Erfolgreiche behandlung einer massiven fulminanten lungenembolie durch streptokinase
50. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
51. Thrombolysis during cardiopulmonary resuscitation in fulminant embolism: A review
52. Intraoperative thrombolyse mit rt-PA bei massiver lungenembolie während venöser thrombektomie
53. Lungenembolien im chirurgischen krankengut. Eine retrospektive studie über 9 jahre
54. Fibrinolyse und thrombolytika
55. Urokinase thrombolytic therapy of pulmonary embolism in neurosurgically treated patients
56. Clinical and hemodynamic correlates in pulmonary embolism
57. Hemodynamic effects of bolus vs. 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial
58. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy
59. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease
60. Modern management of pulmonary embolism
61. Guidelines on diagnosis and management of acute pulmonary embolism
62. The use of inhaled aerosolized prostacyclin in the treatment of pulmonary hypertension secondary to pulmonary embolism